|
Market Closed -
Nasdaq
06:00:00 29/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 137.99 USD | -3.35% |
|
-4.92% | +367.92% |
| 29/08 | BioNTech Terminates Phase 2 Colorectal Cancer Clinical Trial; Shares Fall | MT |
| 29/08 | FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax -- Update | DJ |
| Market Cap | 55.09B 47.47B 44.51B 40.63B 76.54B 5,265B 76.79B 528B 206B 2,658B 207B 202B 8,813B | P/E 2026 * |
-16.2x | P/E 2027 * | -28.1x |
|---|---|---|---|---|---|
| Enterprise Value | 51.44B 44.33B 41.56B 37.94B 71.47B 4,916B 71.7B 493B 192B 2,482B 193B 189B 8,229B | EV / Sales 2026 * |
24.5x | EV / Sales 2027 * | 21.6x |
| Free-Float |
92.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Moderna, Inc.
| 1 day | -3.35% | ||
| 1 week | -4.92% | ||
| Current month | +151.71% | ||
| 1 month | +153.24% | ||
| 3 months | +192.41% | ||
| 6 months | +157.59% | ||
| Current year | +367.92% |
| 1 week | 130 |  | 161.37 |
| 1 month | 52.66 | | 176.66 |
| Current year | 29.81 | | 176.66 |
| 1 year | 22.28 | | 176.66 |
| 3 years | 22.28 | | 176.66 |
| 5 years | 22.28 | | 464.85 |
| 10 years | 11.54 | | 497.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 54 | 01/03/2011 |
James Mock
DFI | Director of Finance/CFO | 49 | 06/09/2022 |
Stephen Hoge
PSD | President | 50 | 01/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Noubar Afeyan
CHM | Chairman | 63 | 01/02/2012 |
Stéphane Bancel
BRD | Director/Board Member | 54 | 01/03/2011 |
Francois Nader
BRD | Director/Board Member | 69 | 11/12/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/8/26 | Fiscal year | Chief Executive Officer | 504,938 | 0.1273% | ||
| 15/7/26 | Fiscal year | Chairperson | 160,008 | 0.0403% | ||
| 8/7/26 | Free | Director | 14,766 | 0.0037% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.35% | -4.92% | +472.81% | +18.97% | 55.09B | |
| -1.67% | -4.78% | +36.76% | -4.34% | 79.3B | |
| -0.90% | +2.39% | -19.06% | -35.50% | 59.21B | |
| -6.78% | -4.19% | -3.45% | +28.35% | 49.86B | |
| -2.43% | -2.35% | +8.33% | +160.40% | 47.9B | |
| -1.35% | +0.79% | +65.25% | -18.47% | 32.28B | |
| -2.64% | -2.69% | +46.99% | +92.55% | 25.21B | |
| -0.09% | +4.98% | +11.00% | +199.86% | 23.87B | |
| -0.34% | +1.35% | +62.33% | +122.21% | 16.89B | |
| +2.73% | 0.00% | -5.13% | +831.69% | 16.17B | |
| Average | -1.68% | -1.09% | +67.58% | +139.57% | 40.58B | |
| Weighted average by Cap. | -2.21% | -1.97% | +80.30% | +73.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.1B 1.81B 1.69B 1.55B 2.91B 200B 2.92B 20.1B 7.84B 101B 7.87B 7.7B 335B | 2.44B 2.11B 1.97B 1.8B 3.39B 234B 3.41B 23.42B 9.14B 118B 9.17B 8.97B 391B |
| Net income | -3.32B -2.86B -2.68B -2.45B -4.61B -317B -4.62B -31.79B -12.4B -160B -12.45B -12.18B -530B | -1.94B -1.67B -1.57B -1.43B -2.7B -186B -2.71B -18.63B -7.27B -93.78B -7.3B -7.14B -311B |
| Net Debt | -3.65B -3.14B -2.95B -2.69B -5.07B -349B -5.09B -34.98B -13.65B -176B -13.7B -13.4B -584B | -2.19B -1.89B -1.77B -1.62B -3.05B -210B -3.06B -21.03B -8.2B -106B -8.24B -8.06B -351B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | USD 137.99 | -3.35% | 25,820,563 |
| 27/08/26 | USD 142.77 | -4.60% | 24,993,236 |
| 26/08/26 | USD 149.66 | -5.77% | 22,009,462 |
| 25/08/26 | USD 158.83 | +14.36% | 49,225,650 |
| 24/08/26 | USD 138.89 | -4.30% | 31,587,240 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRNA Stock
Select your edition
All financial news and data tailored to specific country editions
